annual EBITDA:
$439.77M+$40.01M(+10.01%)Summary
- As of today (May 29, 2025), AMRX annual EBITDA is $439.77 million, with the most recent change of +$40.01 million (+10.01%) on December 31, 2024.
- During the last 3 years, AMRX annual EBITDA has risen by +$38.68 million (+9.64%).
- AMRX annual EBITDA is now at all-time high.
Performance
AMRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$154.58M+$42.11M(+37.44%)Summary
- As of today (May 29, 2025), AMRX quarterly EBITDA is $154.58 million, with the most recent change of +$42.11 million (+37.44%) on March 31, 2025.
- Over the past year, AMRX quarterly EBITDA has increased by +$108.88 million (+238.19%).
- AMRX quarterly EBITDA is now at all-time high.
Performance
AMRX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$548.65M+$108.88M(+24.76%)Summary
- As of today (May 29, 2025), AMRX TTM EBITDA is $548.65 million, with the most recent change of +$108.88 million (+24.76%) on March 31, 2025.
- Over the past year, AMRX TTM EBITDA has increased by +$201.22 million (+57.92%).
- AMRX TTM EBITDA is now at all-time high.
Performance
AMRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.0% | +238.2% | +57.9% |
| 3 y3 years | +9.6% | +90.3% | +45.1% |
| 5 y5 years | +183.4% | +38.9% | +78.4% |
AMRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +192.3% | at high | +212.5% | at high | +376.3% |
| 5 y | 5-year | at high | +192.3% | at high | +212.5% | at high | +376.3% |
| alltime | all time | at high | +462.0% | at high | +179.8% | at high | +1184.3% |
AMRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $154.58M(+37.4%) | $548.65M(+24.8%) |
| Dec 2024 | $439.77M(+10.0%) | $112.47M(-19.6%) | $439.77M(+22.1%) |
| Sep 2024 | - | $139.90M(-1.3%) | $360.32M(+2.5%) |
| Jun 2024 | - | $141.70M(+210.0%) | $351.50M(+1.2%) |
| Mar 2024 | - | $45.71M(+38.4%) | $347.43M(-13.1%) |
| Dec 2023 | $399.76M(+165.8%) | $33.02M(-74.8%) | $399.76M(-14.4%) |
| Sep 2023 | - | $131.07M(-4.8%) | $467.17M(+5.6%) |
| Jun 2023 | - | $137.63M(+40.4%) | $442.27M(+164.5%) |
| Mar 2023 | - | $98.04M(-2.4%) | $167.24M(+11.2%) |
| Dec 2022 | $150.43M(-62.5%) | $100.43M(-5.4%) | $150.43M(+16.8%) |
| Sep 2022 | - | $106.18M(-177.3%) | $128.82M(+11.8%) |
| Jun 2022 | - | -$137.41M(-269.2%) | $115.18M(-69.5%) |
| Mar 2022 | - | $81.23M(+3.1%) | $377.99M(-5.8%) |
| Dec 2021 | $401.10M | $78.82M(-14.8%) | $401.10M(-2.5%) |
| Sep 2021 | - | $92.54M(-26.2%) | $411.21M(+5.2%) |
| Jun 2021 | - | $125.39M(+20.2%) | $391.03M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $104.34M(+17.3%) | $338.62M(-2.0%) |
| Dec 2020 | $345.61M(+122.7%) | $88.93M(+22.9%) | $345.61M(+18.1%) |
| Sep 2020 | - | $72.36M(-0.8%) | $292.69M(-14.5%) |
| Jun 2020 | - | $72.98M(-34.4%) | $342.17M(+11.3%) |
| Mar 2020 | - | $111.33M(+209.1%) | $307.56M(+98.2%) |
| Dec 2019 | $155.20M(+98.3%) | $36.02M(-70.4%) | $155.20M(-20.3%) |
| Sep 2019 | - | $121.84M(+217.6%) | $194.74M(+7.3%) |
| Jun 2019 | - | $38.37M(-193.5%) | $181.51M(-458.7%) |
| Mar 2019 | - | -$41.03M(-154.3%) | -$50.60M(-164.7%) |
| Dec 2018 | $78.25M(-72.9%) | $75.57M(-30.4%) | $78.25M(-19.8%) |
| Sep 2018 | - | $108.61M(-156.1%) | $97.56M(+109.7%) |
| Jun 2018 | - | -$193.74M(-320.6%) | $46.51M(-84.4%) |
| Mar 2018 | - | $87.82M(-7.4%) | $297.58M(+41.9%) |
| Dec 2017 | $288.32M(-4.9%) | $94.87M(+64.8%) | $209.76M(+82.6%) |
| Sep 2017 | - | $57.56M(+0.4%) | $114.89M(+100.4%) |
| Jun 2017 | - | $57.33M | $57.33M |
| Dec 2016 | $303.12M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual EBITDA year-on-year change?
- What is Amneal Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Amneal Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM EBITDA year-on-year change?
What is Amneal Pharmaceuticals annual EBITDA?
The current annual EBITDA of AMRX is $439.77M
What is the all time high annual EBITDA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual EBITDA is $439.77M
What is Amneal Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AMRX annual EBITDA has changed by +$40.01M (+10.01%)
What is Amneal Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of AMRX is $154.58M
What is the all time high quarterly EBITDA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly EBITDA is $154.58M
What is Amneal Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AMRX quarterly EBITDA has changed by +$108.88M (+238.19%)
What is Amneal Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of AMRX is $548.65M
What is the all time high TTM EBITDA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM EBITDA is $548.65M
What is Amneal Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AMRX TTM EBITDA has changed by +$201.22M (+57.92%)